MERCK & CO., INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 130.4 USD | +2.20% |
|
+0.90% | +19.59% |
| May. 02 | Merck: encouraging results in gastric cancer | CF |
| May. 01 | Merck Says Keytruda Meets Primary Endpoint in Late-Stage Gastric Cancer Trial | MT |
ETFs positioned on Merck & Co., Inc.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.68% | 0 M€ | +4.51% | - | |
| 0.67% | 205 M€ | -.--% | ||
| 0.67% | 8 M€ | +5.48% | - | |
| 0.67% | 206 M€ | -.--% | ||
| 0.64% | 5 M€ | -.--% | - | |
| 0.62% | 0 M€ | +18.70% | - | |
| 0.61% | 0 M€ | +7.92% | ||
| 0.56% | 7 M€ | +0.11% | - | |
| 0.56% | 0 M€ | +8.81% | ||
| 0.54% | 14 M€ | +16.19% | - | |
| 0.51% | 1 M€ | +3.03% | - | |
| 0.51% | 0 M€ | +11.74% | - | |
| 0.50% | 1,166 M€ | +0.26% | - | |
| 0.50% | 607 M€ | +0.05% | - | |
| 0.50% | 0 M€ | +3.67% | - | |
| 0.49% | 0 M€ | +17.27% | ||
| 0.46% | 0 M€ | +8.42% | - | |
| 0.40% | 0 M€ | +6.11% | - | |
| 0.39% | 0 M€ | +8.16% | - | |
| 0.36% | 0 M€ | 0.00% | - | |
| 0.33% | 0 M€ | +3.30% | - |
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
Pharmaceuticals
Calendar
2024-05-28
- Annual General Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
130.4
USD
Average target price
141.6
USD
Spread / Average Target
+8.63%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +19.59% | 323B | |
| +33.43% | 690B | |
| +26.43% | 546B | |
| -5.12% | 358B | |
| +4.89% | 287B | |
| +14.32% | 235B | |
| +5.79% | 199B | |
| -9.49% | 195B | |
| +4.26% | 161B | |
| -3.54% | 159B |
- Stock Market
- Equities
- MRK Stock
- Funds and ETFs Merck & Co., Inc.